# Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")

> **NCT04398030** · NA · COMPLETED · sponsor: **Capillary Biomedical, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Type 1 Diabetes

## Interventions

- **DEVICE:** coil-reinforced soft polymer indwelling cannula
- **DEVICE:** soft Teflon indwelling catheter

## Key facts

- **NCT ID:** NCT04398030
- **Lead sponsor:** Capillary Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-17
- **Primary completion:** 2021-04-22
- **Final completion:** 2021-04-22
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-08-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398030, "Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04398030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*